CRISPR Gene editing therapy is used for the first time in living humans with amazing results.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...

India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...

WindRose Health Investors, LLC ("WindRose"), a New York-based healthcare private equity firm, today announced that it has made a strategic investment in Stellus Rx ("Stellus Rx" or the "Company"), a ...

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

NLP Logix, one of the fastest-growing artificial intelligence consultancies in the United States, announced the appointment of D.J. Price as its new Chief Revenue Officer (CRO). Price brings more than ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

The exciting discovery offers a hopeful new idea: A one-time treatment may be able to, someday, replace cholesterol-lowering ...

The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...

Microplastics could be fuelling neurodegenerative diseases like Alzheimer’s and Parkinson’s, with a new study highlighting ...

Here are Cathie Wood’s latest moves.